William Tyndall, MD
Orthopaedic Surgery · Altoona, PANPI 1225133424
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,347 of the $18,265 with a category attached, or 67.6%. 10 manufacturers reported payments, led by Corentec America Inc at 53.5% of the total. Reporting peaked in 2021 at $12,632 and has fallen 94.2% since, to $732 in 2025.
Across 55 payments — averaging $332.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corentec America Inc$10K
- Smith+Nephew$4K
- Catalyst Orthoscience$3K
- Mid-atlantic Surgical Systems, LLC$821
- Arthrex$158
- Amgen$139
- plus $147 from 4 others
Across 27 payments — averaging $13,057 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$193K
- Pacira Therapeutics, Inc.$148K
- Pfizer$11K
- Adaptive Biotechnologies Corporation$908
What the payments were for
- Consulting fees$12,34768%
- Travel & lodging$3,94922%
- Food & beverage$1,94511%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corentec America Inc | 13 | $9,765 |
| Smith+Nephew | 18 | $4,315 |
| Catalyst Orthoscience | 10 | $2,919 |
| Mid-atlantic Surgical Systems, LLC | 3 | $821 |
| Arthrex | 5 | $158 |
| Amgen | 1 | $139 |
| Medacta USA, Inc. | 1 | $82 |
| Bioventus LLC | 2 | $38 |
| Johnson & Johnson | 1 | $13 |
| Stryker | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Catalyst Total CSR$2,725
- FLOW 50/90$786
- DYONICS 25$786
- Q-Fix Mini$786
- Elite Hip Instruments$751
- SPEEDLOCK HIP$751
- Latarjet System$360
- Hip Pac$314
- EVENITY$139
- Prolia$139
- Q-FIX$133
- ACCUPASS DIRECT Crescent XL$133
- BIORAPTOR$133
How this compares
$18,265 in reported general payments places this provider in the 75th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 311 | $8,287 |
| Cefadroxil | 148 | $1,622 |
| Oxycodone Hcl | 156 | $757 |
| Ondansetron Hcl | 190 | $617 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 62 | $432 |
| Cefazolin Sodium | 45 | $344 |
| Dexamethasone Sodium PhosphateDexamethasone Sodium Phosp/Pf | 41 | $264 |
| Meloxicam | 30 | $103 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $91 |
| Tramadol Hcl | 28 | $65 |
| Amoxicillin | 34 | $39 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Altoona
- William HozackBensalem$10.6M
- Jess LonnerBryn Mawr$7.8M
- Gerald WilliamsBryn Mawr$6.8M
- Mark LazarusBensalem$6.4M
- John FenlinPhiladelphia$5.9M
- Peter SharkeyKing Of Prussia$5.7M
- Alexander VaccaroPhiladelphia$4.5M
- Selene ParekhBensalem$4.5M
- Joseph AbboudPhiladelphia$3.9M
- Jonathan GarinoMalvern$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.